Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

Objective: This study aimed to determine the long-term survival of patients with cT4 esophageal cancer (EC) and whether neoadjuvant chemoradiotherapy/radiotherapy plus surgery (nCRT/RT + S) is superior to definitive CRT(dCRT)/RT in terms of survival in cT4 EC downstaged after nCRT/RT. Summary backgr...

Full description

Bibliographic Details
Main Authors: Lin-Rui Gao, Chen Li, Weiming Han, Wenjie Ni, Wei Deng, Lijun Tan, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Wenqing Wang, Wenyang Liu, Lei Deng, Xin Wang, Tao Zhang, Jianyang Wang, Yirui Zhai, Nan Bi, Lvhua Wang, Zhouguang Hui, Ye-Xiong Li, Zefen Xiao
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221108693

Internet

https://doi.org/10.1177/17588359221108693

Similar Items